This review discusses two prospective cohort studies that evaluated the prognostic value of ANGPTL2 in individuals with type 2 diabetes, focusing on the risks of lower-extremity artery disease (LEAD) and peripheral arterial disease (PAD) [17,18]. This evidence concerns the gene ANGPTL2 and peripheral arterial disease.